Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Mesothelioma 1 Adenomatous Polyposis Coli 1

Interventions

pembrolizumab 55 Carboplatin 33 Paclitaxel 24 Cyclophosphamide 23 Capecitabine 18 sacituzumab govitecan 16 130-nm albumin-bound paclitaxel 15 Specimen Handling 14 toripalimab 11 Drug Therapy 11 Magnetic Resonance Spectroscopy 10 Biopsy 10 Bevacizumab 10 Taxes 9 Epirubicin 9 durvalumab 8 Albumin-Bound Paclitaxel 8 olaparib 7 camrelizumab 7 Gemcitabine 7 Doxorubicin 7 Docetaxel 7 fludarabine 6 famitinib 5 Nivolumab 5 Injections 5 atezolizumab 4 abemaciclib 4 Trastuzumab 4 Standard of Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Triple Negative Breast Neoplasms × Exercise Therapy × Clear all

NCT06831955 2026-03-20

LESLIE

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡